Case File
efta-efta00602782DOJ Data Set 9OtherApril 23, 2014
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00602782
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
April 23, 2014
Jeffrey Epstein
ADDRESS
Dear Mr. Epstein:
This letter sets forth our agreement on the terms under which xxx, LLC ("you") is
subscribing as a limited partner in Boothbay Multi-Strategy Fund, LP. It is understood
that your subscription in Boothbay Multi-Strategy Fund, LP is being made on an interim
basis, with a view toward transferring your investment to a new Boothbay Fund that will
be launched within the next few months.
The Private Placement Memorandum ("PPM") of Boothbay Multi-Strategy Fund,
LP states that management fees will be 1% and performance fees will be 15% and a one
year lock-up will apply. For this interim period, you will be only charged a 1%
management fee and a 10% performance fee with a lock-up until December 31, 2014. As
mentioned, the intent is to move your capital investment to a new Boothbay Fund within
the next few months and we expect a PPM for the new Boothbay fund within the next
two weeks. The time that you are invested in the Boothbay Multi-Strategy Fund will be
included when determining "start date of investment" as it relates to lockup provisions.
Your investment in Boothbay Multi-Strategy Fund LP will be transferred directly to the
new Boothbay Fund. This transfer is contingent on your approving the PPM for the new
fund.
The terms of your investment in the new fund will be based on the Founder's
Share Class rates. The rates are dependent on the length of the initial investment. If the
investment is for 1 year, the management fee will be I% instead of the anticipated
management fee of 1.25% for the later share classes. The performance fee will be 15% of
the net gain allocated to your capital account instead of the anticipated performance fee
of 20% for the later share classes. If the investment is for 2 years, the management fee
will be 1% instead of the anticipated management fee of 1.25% for the later share classes.
The performance fee will be 12.5% of the net gain allocated to your capital account
instead of the anticipated performance fee of 17.5% for the later share classes. The lock-
up will be waived if there is a loss of principal equaling 6.67% of your capital account. In
the event the new Boothbay Fund is not launched by December 31, 2014, which is not
anticipated as we hope to have it launched in June or July of this year, you may request
the withdrawal of all or any portion of your capital account in Boothbay in accordance
with the terms of Boothbay's PPM.
Very truly yours,
Ari Glass
Managing Member
EFTA00602782
XXX, LLC
April 23, 2014
Page 2
Agreed and accepted:
Xxx, LLC
Jeffrey Epstein
Managing Member
EFTA00602783
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.